Correlation Between Precision BioSciences and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both Precision BioSciences and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Precision BioSciences and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Precision BioSciences and Champions Oncology, you can compare the effects of market volatilities on Precision BioSciences and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Precision BioSciences with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Precision BioSciences and Champions Oncology.
Diversification Opportunities for Precision BioSciences and Champions Oncology
-0.81 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Precision and Champions is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding Precision BioSciences and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Precision BioSciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Precision BioSciences are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Precision BioSciences i.e., Precision BioSciences and Champions Oncology go up and down completely randomly.
Pair Corralation between Precision BioSciences and Champions Oncology
Given the investment horizon of 90 days Precision BioSciences is expected to generate 3.22 times less return on investment than Champions Oncology. In addition to that, Precision BioSciences is 1.15 times more volatile than Champions Oncology. It trades about 0.06 of its total potential returns per unit of risk. Champions Oncology is currently generating about 0.24 per unit of volatility. If you would invest 820.00 in Champions Oncology on November 2, 2024 and sell it today you would earn a total of 250.00 from holding Champions Oncology or generate 30.49% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Precision BioSciences vs. Champions Oncology
Performance |
| Timeline |
| Precision BioSciences |
| Champions Oncology |
Precision BioSciences and Champions Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Precision BioSciences and Champions Oncology
The main advantage of trading using opposite Precision BioSciences and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Precision BioSciences position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.| Precision BioSciences vs. X4 Pharmaceuticals | Precision BioSciences vs. Acumen Pharmaceuticals | Precision BioSciences vs. Inozyme Pharma | Precision BioSciences vs. Terns Pharmaceuticals |
| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |